THC
Director Trades
| Date | Director | Value |
|---|
Company News
THC Global reveals major strategic changes as part of broader shift into healthcare and pharmaceuticals
Medicinal cannabis company THC Global (ASX: THC) has revealed several major strategic shifts to carve a bigger slice of the wider healthcare and pharmaceutical markets including a rebranding to reflect the move. As part of the rebrand, THC will be renamed Epsilon Healthcare. Shareholders will be required to approve the change at an extraordinary general […]
THC Global signs cannabis medicine production deal with local cultivator Cannatrek
THC Global Group (ASX: THC) has signed a 12-month supply and production deal with Australian “seed-to-patient” medical cannabis business Cannatrek to develop and manufacture Cannatrek-branded medicines on contract. Under the terms of the agreement, Cannatrek will provide dried cannabis flower to THC for production of oil-based medical cannabis marketed under the Cannatrek brand. It will […]
THC Global releases first locally-made medicinal cannabidiol for Australian patients
The first Australian-produced full-spectrum medicinal cannabidiol manufactured by diversified cannabis company THC Global (ASX: THC) has become available for prescription to Australian patients under the country’s Special Access Scheme. Marketed under THC’s flagship Canndeo brand, the medicine has been developed entirely in Australia using cannabis sourced from THC’s Bundaberg cultivation facility in Queensland. It was […]
THC Global to acquire Tetra Health network of medicinal cannabis clinics
THC Global Group (ASX: THC) will pay $3 million in shares and cash to acquire the Tetra Health network of clinics which provide access to legal medicinal cannabis. Tetra’s network comprises over 630 referring and prescribing physicians, as well as dispensing pharmacies across Australia. It generates revenue primarily from consultation fees charged to over 1,100 […]
THC Global sets date for first Australian medicinal cannabis prescriptions, eyes German export market
THC Global (ASX: THC) has set a firm date for when its Australian-made Canndeo branded medicinal cannabis medicines will be made available for prescription in Australia. The company’s chief executive officer Ken Charteris declared that THC Global would offer its medicinal cannabis products under the Canndeo brand as of 20 May this year while offering […]
THC Global secures expanded cultivation permit, production underway for Australian patients
Medicinal cannabis developer THC Global (ASX: THC) has updated the market with news that it has received an expanded commercial cultivation permit from the Australian Office of Drug Control (ODC). THC is the first ASX-listed company to fully own and operate commercial medicinal cannabis production facilities under Australia’s cannabis regulations. The updated permit means THC can […]
THC Global gets green light for commercial-scale medicinal cannabis production
THC Global Group (ASX: THC) is poised to commence commercial-scale production of medicinal cannabis after its pharmaceutical bio-floral extraction facility in Queensland was granted a manufacturing licence from the Australian Therapeutic Goods Administration. The internationally-recognised GMP (Good Manufacturing Practice) licence rounds out the series of permits the company is required to gain to enable commercial […]
THC Global produces its first batch of medicinal cannabis in Australia
After several years of planning and navigating an exhaustive path of obtaining regulatory approvals, medicinal cannabis developer THC Global (ASX: THC) has finally completed its first round of “farm-to-pharma” cannabis processing. The company has commenced operations at its Southport manufacturing facility in Queensland, considered to be the largest pharmaceutical bio-floral extraction facility in the southern hemisphere. […]
THC Global to begin cannabis production at Southport facility following ODC permit
Medicinal cannabis developer THC Global (ASX: THC) has received the green light to manufacture cannabis at its Southport facility in Australia by the country’s regulator, the Office of Drug Control (ODC). The highly anticipated approval means that THC will now move to kick-off production of high-grade cannabis and add to the growing supply that is seeking […]
THC Global reports revenue in NZ and Canada, sets stage for Australian production
Medicinal cannabis developer THC Global (ASX: THC) has published an interim update of its market performance in which it reaffirmed its target of completing product validation at its Southport manufacturing facility by the end of December 2019. From a financial perspective, THC Global confirmed that in addition to the $4.02 million in cash held at […]
Company Videos
No videos found.